Raymond James advised Amedisys (NASDAQ:AMED) in the Company’s acquisition of TLC Health Care Services, a privately-owned home health and hospice provider. TLC has 92 home health and 11 hospice agencies located in 22 states and the District of Columbia and is being sold by Arcapita, an Atlanta-based private equity firm.

Raymond James provided a full range of advisory services including: (i) negotiation and structuring of the initial letter of intent and definitive stock purchase agreement, (ii) managed and coordinated an extensive due-diligence process; (iii) assisted Amedisys in developing and refining its detailed projection model and supporting analyses for distribution to potential underwriters; (iv) developed and updated transaction overview and valuation materials for the Amedisys Board of Directors; and (v) advised management on market communication strategy.

Raymond James previously served as lead manager for the Amedisys’ $124.5 million follow-on offering in November 2006 and $75.9 million follow-on offering in September 2004 and also advised the Company in their acquisition of Housecall Medical Resources, the Company’ largest prior to TLC. John Ransom covers the Company from a research standpoint, with Raymond James as a top trader of Amedisys equity.

On February 19, 2008, Amedisys announced it had signed a definitive agreement to acquire TLC for $395.0 million in cash using proceeds from a new $500.0 million acquisition credit facility. After the close of the transaction, Amedisys now has over 480 home health agencies in 35 states and Puerto Rico with TTM revenue of over $1.0 billion. The transaction closed on March 27th, 2008.